JKN2304 inhalation solution

· Joincare Pharmaceutical Group Industry Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JKN2304 inhalation solution, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD [Phase 2]